EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
4 hedge funds and large institutions have $2.99M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$34.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$108 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EC
1
EcoR1 Capital
San Francisco,
California
| $2.03M | – | – | – |
|
|
SIA
2
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $728K | – | – | – |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $222K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $7K | -$108 | -10 | -2% |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$34.8K | -3,483 | Closed |
|